Cargando…
Targeting the epigenetics of the DNA damage response in breast cancer
Cancer is as much an epigenetic disease as it is a genetic disease, and epigenetic alterations in cancer often serve as potent surrogates for genetic mutations. Because the epigenetic factors involved in the DNA damage response are regulated by multiple elements, therapies to target specific compone...
Autores principales: | Montenegro, M F, González-Guerrero, R, Sánchez-del-Campo, L, Piñero-Madrona, A, Cabezas-Herrera, J, Rodríguez-López, J N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855664/ https://www.ncbi.nlm.nih.gov/pubmed/27054335 http://dx.doi.org/10.1038/cddis.2016.85 |
Ejemplares similares
-
PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation
por: Montenegro, María F., et al.
Publicado: (2020) -
Reactivation of the Tumour Suppressor RASSF1A in Breast Cancer by Simultaneous Targeting of DNA and E2F1 Methylation
por: Montenegro, María F., et al.
Publicado: (2012) -
MITF induces escape from innate immunity in melanoma
por: Sánchez-del-Campo, Luis, et al.
Publicado: (2021) -
Targeting protein methylation in pancreatic cancer cells results in KRAS signaling imbalance and inhibition of autophagy
por: Montenegro, María F., et al.
Publicado: (2023) -
Acriflavine, a Potent Inhibitor of HIF-1α, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-hypoxic Conditions
por: Martí-Díaz, Román, et al.
Publicado: (2020)